Earnings summaries and quarterly performance for CLOVER HEALTH INVESTMENTS, CORP. /DE.
Executive leadership at CLOVER HEALTH INVESTMENTS, CORP. /DE.
Andrew Toy
Detailed
Chief Executive Officer
CEO
BP
Brady Priest
Detailed
Chief Executive Officer of Home Care
CW
Conrad Wai
Detailed
Chief Executive Officer of Counterpart Health
JR
Jamie Reynoso
Detailed
Chief Executive Officer of Medicare Advantage
KS
Karen Soares
Detailed
General Counsel and Corporate Secretary
PK
Peter Kuipers
Detailed
Chief Financial Officer
Board of directors at CLOVER HEALTH INVESTMENTS, CORP. /DE.
Research analysts who have asked questions during CLOVER HEALTH INVESTMENTS, CORP. /DE earnings calls.
MH
Matthew Hewitt
Craig-Hallum Capital Group LLC
3 questions for CLOV
Also covers: ACET, APYX, BHST +21 more
JY
Jonathan Yong
UBS
2 questions for CLOV
Also covers: ALHC, EHTH, OSCR
JY
Jonathan Young
Cantor Fitzgerald
2 questions for CLOV
Also covers: BCS
John French
Leerink Partners
1 question for CLOV
John Pinney
Canaccord Genuity Group Inc.
1 question for CLOV
Also covers: AHCO, HSTM, QIPT
Richard Close
Canaccord Genuity Group
1 question for CLOV
Also covers: ACCD, AHCO, DCGO +15 more
Recent press releases and 8-K filings for CLOV.
Clover Health Targets GAAP Net Income Profitability and Reports Strong Member Growth
CLOV
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- Clover Health achieved Adjusted EBITDA profitability last year and is targeting GAAP net income profitability this year (2026).
- The company reported 53% year-on-year member growth, expanding its base from approximately 100,000 to over 150,000 members.
- This growth is supported by tailwinds for 2026, including a four-star payment year, increased CMS rates, and high member retention.
- Clover Health leverages its AI-driven Clover Assistant technology to improve clinical outcomes and drive profitability, particularly as returning member cohorts become more profitable over time.
4 days ago
Clover Health Projects 2026 GAAP Net Income Profitability and Reports Strong MA Membership Growth
CLOV
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- Clover Health expects FY26 GAAP Net Income Profitability and is targeting sustained Adjusted EBITDA Profitability.
- The company reported Medicare Advantage (MA) membership growth of +53% for the 2026 Annual Enrollment Period (AEP), reaching approximately 153,000 members as of January 2026.
- Clover Health's PPO plans achieved the #1 national score on HEDIS quality measures for Plan Year 2026, Payment Year 2027 Star ratings, with a score of 4.72.
- The Insurance BER (Non-GAAP) was 93.5% for Q3 2025 and 89.4% for the nine months ended September 30, 2025. The Normalized Insurance BER (Non-GAAP) was 92.4% for Q3 2025 and 88.9% for the nine months ended September 30, 2025.
- The AI-powered Clover Assistant is expanding its 3rd party customer base and onboarding more clinicians, contributing to improved clinical outcomes and cohort economics.
4 days ago
Clover Health Reports Strong Growth and Aims for GAAP Net Income Profitability in 2026
CLOV
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- Clover Health achieved 53% year-on-year growth and is targeting GAAP net income profitability in 2026, building on its existing Adjusted EBITDA profitability.
- The company maintains its position as the number one PPO in the country in Medicare Advantage on HEDIS quality for the second consecutive year, attributing this to its AI-driven Clover Assistant technology.
- Clover Health's Counterpart Health business is expanding, bringing its technology platform to other Medicare Advantage plans and risk-bearing providers, with the software already deployed in markets outside its own plan.
- The company anticipates a four-star payment year in 2026 and expects to improve SG&A efficiency through AI-driven initiatives in the coming years.
4 days ago
Clover Health Reports Strong Growth and Aims for GAAP Profitability in 2026
CLOV
Revenue Acceleration/Inflection
Guidance Update
New Projects/Investments
- Clover Health reported 53% year-on-year membership growth, expanding from approximately 100,000 to over 150,000 members.
- The company has achieved Adjusted EBITDA profitability and is now targeting GAAP net income profitability for fiscal year 2026.
- Clover Health maintained its position as the number one PPO in Medicare Advantage on HEDIS quality for the second consecutive year, attributing this to its AI-powered Clover Assistant technology.
- The company is also expanding its technology offering to other health plans through its Counterpart Health subsidiary.
4 days ago
Clover Health Announces Strong Medicare Advantage Membership Growth and Expects 2026 GAAP Net Income Profitability
CLOV
Revenue Acceleration/Inflection
Guidance Update
- Clover Health announced 53% year-over-year membership growth in its Medicare Advantage (MA) PPO plans for the 2026 plan year, reaching approximately 153,000 members as of January 1, 2026.
- The company expects to achieve its first-ever full year GAAP Net Income profitability in 2026.
- This growth was achieved through disciplined expansion in core markets, strong returning member retention of >95%, and stable plan benefits.
- Approximately 97% of the January 1, 2026 membership is in Clover's flagship PPO plan, which is ranked #1 nationally on core HEDIS metrics and will be paid on 4.0 Stars for Payment Year 2026.
5 days ago
Clover Health Targets FY26 GAAP Net Income Profitability and Reports Strong Membership Growth
CLOV
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- Clover Health anticipates GAAP Net Income Profitability for fiscal year 2026 and is targeting Sustained Adjusted EBITDA Profitability.
- The company achieved market-leading Medicare Advantage membership growth of +53% year-over-year to approximately 153,000 members in January 2026, up from +27% in January 2025.
- Clover Health's PPO plans were ranked the #1 PPO Plan Nationally on HEDIS Quality for Plan Year 2026, Payment Year 2027 Star ratings, with a score of 4.72.
- The company expects a >$70 PMPM revenue tailwind from its 4-Star rating and favorable rate updates, complementing its membership growth.
- The AI-powered Clover Assistant clinical software is rapidly expanding its 3rd party customer base and is shown to improve MCR by over 1,500 basis points for members whose PCPs use it.
5 days ago
Counterpart Health, a Clover Health Subsidiary, Releases 2025 Highlights
CLOV
Product Launch
New Projects/Investments
- Counterpart Health, a subsidiary of Clover Health, reported a > 450% Year-over-Year increase in live third-party customer clinicians in 2025, now serving hundreds of clinicians.
- The platform demonstrated significant financial and clinical outcomes, including an approximate 1,500 basis point MCR differential for returning Clover Health members whose primary care physicians use Counterpart Assistant compared to those who do not.
- Counterpart's technology supported the #1 HEDIS score nationwide for a PPO Medicare Advantage plan for the second consecutive year and showed clinical improvements such as new members being 75% more likely to be diagnosed with COPD and an 18% lower rate of all-cause hospitalizations for Congestive Heart Failure.
- In 2025, Counterpart expanded its technological capabilities to become an end-to-end clinical operating system, introducing features like Integrated Ambient Scribing and Natural Language Chat.
7 days ago
Clover Health's Counterpart Health Subsidiary Releases Positive AI Platform Data
CLOV
New Projects/Investments
Product Launch
- Clover Health Investments (NASDAQ: CLOV), through its Counterpart Health subsidiary, released whitepaper data demonstrating its Counterpart Assistant AI platform supports earlier disease detection and reduced hospitalizations in underserved populations.
- The platform showed 75% higher diagnosis rates for diabetes, 89% higher for chronic kidney disease, and 89% higher for chronic heart failure in patients attributed to physicians using the technology, compared to control groups.
- Additionally, the AI platform was associated with a significant reduction in all-cause inpatient hospitalizations, ranging from 7.6% to 21.2%.
- This is the sixth retrospective analysis by Counterpart Health on the clinical impact of its AI-powered physician enablement technology.
Dec 8, 2025, 6:17 PM
Clover Health Discusses Growth, Profitability Outlook, and Technology at Citi Global Healthcare Conference
CLOV
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
- Clover Health reported 33% year-to-date membership growth as of September 30, 2025, and $45 million in year-to-date adjusted EBITDA.
- The company anticipates achieving GAAP net income profitability for fiscal 2026.
- Its proprietary Clover Assistant technology significantly improves the Medical Cost Ratio (MCR) by 700 basis points from year one to year two, and an additional 700 basis points from year two to year three.
- New members incur a contribution profit loss of approximately $110 per member per month (PMPM), while returning members generate a profit of $217 PMPM.
- For 2026, Clover Health expects roughly similar growth in new members and anticipates financial tailwinds from a four-star payment year, which translates to almost a 5% increase to the top line.
Dec 4, 2025, 4:15 PM
Clover Health Reports Strong Membership Growth and Targets 2026 GAAP Net Income Profitability
CLOV
Revenue Acceleration/Inflection
Guidance Update
New Projects/Investments
- Clover Health reported 33% year-to-date membership growth and $45 million in year-to-date Adjusted EBITDA as of September 30, 2025, and anticipates achieving GAAP net income profitability for fiscal 2026.
- The company's proprietary AI-powered Clover Assistant technology contributes to a medical cost ratio (MCR) improvement of approximately 700 basis points from year one to year two for returning members, and an additional 700 basis points from year two to year three, totaling a 1,400 basis point improvement from year one.
- New members typically result in a contribution profit loss of about $110 per member per month (PMPM), while returning members generate approximately $217 PMPM in profit, with both figures expected to improve in 2026.
- Clover Health will benefit from a four-star payment year in 2026, which is projected to provide an almost 5% increase to the top line.
Dec 4, 2025, 4:15 PM
Quarterly earnings call transcripts for CLOVER HEALTH INVESTMENTS, CORP. /DE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more